CME Group Inc. would find it hard to counter Deutsche Boerse AG’s takeover bid for NYSE Euronext because of the steep breakup fee on the cross-Atlantic deal, CME’s executive chairman said.
Asked if CME would like to buy NYSE’s UK-based derivatives exchange, CME’s Terrence Duffy told CNBC he “would obviously love to take a look,” if it were available for sale.
But the expensive breakup fee would make it difficult for CME or another firm to make a counter offer, he said.
